According to CareDx's latest financial reports the company's current revenue (TTM) is $0.28 B. In 2022 the company made a revenue of $0.32 B an increase over the years 2021 revenue that were of $0.29 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.28 B | -12.89% |
2022 | $0.32 B | 8.57% |
2021 | $0.29 B | 54.22% |
2020 | $0.19 B | 51.25% |
2019 | $0.12 B | 65.95% |
2018 | $76.56 M | 58.45% |
2017 | $48.32 M | 18.93% |
2016 | $40.63 M | 44.37% |
2015 | $28.14 M | 3.07% |
2014 | $27.3 M | 23.57% |
2013 | $22.09 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
T2 Biosystems
TTOO | $7.19 M | -97.43% | ๐บ๐ธ USA |
Agios Pharmaceuticals
AGIO | $26.82 M | -90.43% | ๐บ๐ธ USA |
Invitae
NVTA | $0.48 B | 71.80% | ๐บ๐ธ USA |